Biotechnology News

April 5, 2012

SAN DIEGO & BALTIMORE--(BUSINESS WIRE)--Ridge Diagnostics has entered into an exclusive agreement with Ameritox for license rights to its proprietary developmental blood test MDDScore, a biomarker analysis for Major Depressive Disorder.

April 5, 2012

WASHINGTON--(BUSINESS WIRE)--BIO announces the redesign of the primary e-newsletter, Biotech NOW, which will now be called BIO Communiqué.

April 5, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using...

April 5, 2012

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation Q1 2012 Financial Results Webcast Invitation

April 5, 2012

CLEVELAND--(BUSINESS WIRE)--Cleveland HeartLab, a specialty clinical laboratory and cardiovascular disease management company, today announced that its inflammation biomarker panel will be featured at next week's TEDMED 2012.

April 5, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis collaborates with Karolinska Institutet

April 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tobira Therapeutics appoints Antoun Nabhan, JD, VP, Business Development, responsible for strategic transactions, partnering activities, and certain operating activities.

April 5, 2012

CINCINNATI--(BUSINESS WIRE)--Akebia Therapeutics, Inc., a pharmaceutical discovery and development company focused on anemia and vascular disorders, today announced that it has successfully completed a randomized, double-blinded, placebo-...

April 5, 2012

DENVER--(BUSINESS WIRE)--Four industry executives were named to the Colorado BioScience Association (CBSA) Board of Directors at its 2012 Annual All-Member Meeting.

April 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus publishes adenosine A2A and beta-2 adrenergic agonists as synergistic, selective agents that enhance activity in multiple myeloma

April 5, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo reports positive results from an open-label phase 3 clinical trial designed to evaluate the long-term safety and efficacy of lubiprostone in chronic non-cancer pain patients with OBD.

April 5, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Acquire Allos Therapeutics

April 5, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--In this three-part webinar series, learn how you can manage tourniquet time in your TKA.

April 5, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Results of Apaziquone Phase 3 Trials

April 5, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark and Advanced Liquid Logic enter into agreement to develop an all-electronic fully integrated diagnostic platform

April 5, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: As from today, Biotage’s (STO:BIOTA) Annual Report and Corporate Governance Report for 2011 are available at: www.biotage.com Biotage discloses the information provided herein pursuant to the...

April 5, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--Media alert announcing hepatitis C abstracts to be presented by Boehringer Ingelheim at the International Liver Congress 2012 (EASL).

April 5, 2012

NEW DELHI--(BUSINESS WIRE)--AB SCIEX and Phenomenex announce a new workflow solution tailored for labs in India to ensure the safety of spices, teas, fruits, vegetables and other food for domestic and export markets.

April 5, 2012

ZURICH-SCHLIEREN, Switzerland--(BUSINESS WIRE)--Molecular Partners comments on Allergan's Phase II Retinal Disease Clincial Trial using DARPins

April 5, 2012

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive agreement to acquire Oridion Systems Ltd....

April 4, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River schedules first-quarter 2012 earnings call for May 3rd at 8:30am EDT

April 4, 2012

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) has completed the acquisition of ALS Distribuidora Limitada (“ALS”), a privately-held Chilean pharmaceutical company engaged in the business of importation, commercialization and distribution...

April 4, 2012

SANTA MONICA, Calif.--(BUSINESS WIRE)--Acting like Trojan horses, targeted nanoparticles can now deliver high doses to chemotherapy agents, such as docetaxel for prostate cancer, directly to cancer cells while sparing healthy cells.

April 4, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Results in Science Translational Medicine Highlight New Class of Targeted Cancer Therapeutics Showing Promising Clinical Effects in Advanced or Metastatic Cancers

April 4, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is happy to report that patient #2, who had a Squamous cell carcinoma on her...

April 4, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced the appointment of Brian Farley to the company’s board of...

April 4, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--IntegraGen, Inc., a biotechnology company dedicated to molecular biomarker discovery, today announced the launch of the ARISk™ Risk Assessment Test, a gender specific, genetic screening test that looks at 65...

April 4, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that 20 abstracts on the Company’s research in liver disease have been accepted for presentation at The International Liver CongressTM 2012, the 47th annual...

April 4, 2012

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir AB (OMX: MVIR), a research-based specialty pharmaceutical company focused on infectious diseases, today announces that four abstracts related to its once daily (QD), oral investigational...

April 4, 2012

BOULDER, Colo.--(BUSINESS WIRE)--The Gynecologic Oncology Group presented results of a Phase 2 trial with selumetinib, a small-molecule MEK inhibitor, in women with recurrent low-grade serous ovarian or peritoneal cancer at the American...

April 4, 2012

SOMERSET, N.J. & LUDWIGSHAFEN, Germany--(BUSINESS WIRE)--Catalent Pharma Solutions and BASF have entered into a broad collaboration and Open Alliance to provide solutions to overcome bioavailability challenges of new molecular entities with...

April 4, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta presented preclinical results on the use of ganetespib, in melanoma and colorectal cancer at the 103rd Annual Meeting American Association for Cancer Research (AACR).

April 4, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--Phase 2 Clinical Trial Results: VEN100 Reduces Antibiotic-Associated Diarrhea by 50% in High-Risk Patients

April 4, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Late-Breaker Clinical Data Presented at AACR 2012 Annual Meeting for BIND-014, Lead Candidate from BIND’s Accurin Platform for Targeted and Programmable Nanomedicines

April 4, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2012 before the market opens on Wednesday, April 25, 2012...

April 4, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The American Diabetes Association has signed a strategic agreement with Quintiles’ Digital Patient Unit which will provide access to Quintiles’ MediGuard.org medication monitoring service.

April 4, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Georgian Radiology Consultants (Barrie, Ontario) installed new, advanced digital X-ray systems at six imaging clinics that serve more than 360,000 community residents.

April 4, 2012

TUCSON, Ariz., & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Muscular Dystrophy Association announced today that it has awarded $120,000 to Cambridge, Mass.-based Catabasis Pharmaceuticals as part of a strategic partnership under which the...

April 4, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it was awarded U.S. Patent 8,148,414 for “Prodrugs of Methyl Hydrogen Fumarate, Pharmaceutical Compositions Thereof, and Methods of Use.” The term of the...

April 4, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“IMUC” or the “Company”) (OTCBB: IMUC), a clinical-stage biotechnology company that is focused on developing new immune-based products to treat and diagnose cancer, announced today...

April 4, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that its first quarter 2012 financial results will be released before the market opens on Tuesday, May 1, 2012 and will be available on Impax’s Web site at...

April 4, 2012

MINNETONKA, Minn.--(BUSINESS WIRE)--Anulex Technologies, Inc. Receives FDA Clearance for Expanded Indications of fiXate™ Tissue Band.

April 4, 2012

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen today announced that it has completed the appointment of its nine-member US Leadership Team, tasked with advancing business and commercialization activities for its specialty medicines.

April 4, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets....

April 4, 2012

BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor immune status in transplant recipients and...

April 4, 2012

NEW YORK--(BUSINESS WIRE)--The New York Genome Center (NYGC) today announced that it has been selected to receive a generous grant from the Alfred P. Sloan Foundation to help build the infrastructure needed to support a large-scale genome...

April 4, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that the Company has submitted to the U.S. Food and Drug Administration (FDA) a complete response to the FDA’s letter regarding the previously announced Full Clinical Hold...

April 4, 2012

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--The patented BMB is a single platform which can be utilized from Biomarker Discovery directly to In-Vitro Diagnostics. This approach enables users to optimize efficiency and maximize resources.

April 4, 2012

SYDNEY--(BUSINESS WIRE)--Following the merger of private drug developer Hunter Immunology Limited with Probiomics Limited (ASX: PCC), the merged entity today recommenced trading on the Australian Securities Exchange (ASX).